» Articles » PMID: 39076867

Alterations in Coronary Resistance Artery Network Geometry in Diabetes and the Role of Tenascin C

Abstract

Background: Geometrical alterations in the coronary resistance artery network and the potential involvement of Tenascin C (TNC) extracellular matrix protein were investigated in diabetic and control mice.

Methods: Diabetes was induced by streptozotocin (STZ) injections (n = 7-11 animals in each group) in Tenascin C KO (TNC KO) mice and their Wild type (A/J) littermates. After 16-18 weeks the heart was removed and the whole subsurface network of the left coronary artery was prepared (down to branches of 40 m outer diameter), pressure-perfused and studied using video-microscopy. Outer and inner diameters, wall thicknesses and bifurcation angles were measured on whole network pictures reconstructed into collages at 1.7 m pixel resolutions.

Results: Diabetes induced abnormal morphological alterations including trifurcations, sharp bends of larger branches, and branches directed retrogradely ( 0.001 by the test). Networks of TNC KO mice tended to form early divisions producing parallelly running larger branches ( 0.001 by the probe). Networks of coronary resistance arteries were substantially more abundant in 100-180 m components, appearing in 2-5 mm flow distance from orifice in diabetes. This was accompanied by thickening of the wall of larger arterioles ( 220 m) and thinning of the wall of smaller (100-140 m) arterioles ( 0.001). Blood flow should cover larger distances in diabetic networks, but interestingly STZ-induced diabetes did not generate further geometrical changes in TNC KO mice.

Conclusions: Diabetes promotes hypertrophic and hypotrophic vascular remodeling and induces vasculogenesis at well defined, specific positions of the coronary vasculature. TNC plays a pivotal role in the formation of coronary network geometry, and TNC deletion causes parallel fragmentation preventing diabetes-induced abnormal vascular morphologies.

References
1.
Nemes A, Forster T, Lengyel C, Csanady M . Reduced aortic distensibility and coronary flow velocity reserve in diabetes mellitus patients with a negative coronary angiogram. Can J Cardiol. 2007; 23(6):445-50. PMC: 2650663. DOI: 10.1016/s0828-282x(07)70782-1. View

2.
Miki T, Yuda S, Kouzu H, Miura T . Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2012; 18(2):149-66. PMC: 3593009. DOI: 10.1007/s10741-012-9313-3. View

3.
Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M . Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci. 1999; 40(6):1071-80. View

4.
Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, Arima M . Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. Mol Vis. 2016; 22:436-45. PMC: 4859161. View

5.
Radwanska A, Grall D, Schaub S, Beghelli-de la Forest Divonne S, Ciais D, Rekima S . Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells. Sci Rep. 2017; 7(1):12762. PMC: 5630602. DOI: 10.1038/s41598-017-13008-9. View